Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Repligen Corp before investing.

In this article, we go over a few key elements for understanding Repligen Corp’s stock price such as:

• Repligen Corp’s current stock price and volume
• Why Repligen Corp’s stock price changed recently
• Upgrades and downgrades for RGEN from analysts
• RGEN’s stock price momentum as measured by its relative strength

About Repligen Corp (RGEN)

Before we jump into Repligen Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Want to learn more about Repligen Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Repligen Corp.

Repligen Corp’s Stock Price as of Market Close

As of August 16, 2024, 4:00 PM, CST, Repligen Corp’s stock price was $147.55.

Repligen Corp is down 9.26% from its previous closing price of $162.61.

During the last market session, Repligen Corp’s stock traded between $160.48 and $165.50. Currently, there are 55.88 million shares of Repligen Corp stock available for purchase.

Unfortunately, Repligen Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Repligen Corp Stock Price History

Repligen Corp’s (RGEN) price is currently down 11.83% so far this month.

During the month of August, Repligen Corp’s stock price has reached a high of $172.65 and a low of $140.19.

Over the last year, Repligen Corp has hit prices as high as $211.13 and as low as $110.45. Year to date, Repligen Corp’s stock is down 12.85%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Repligen Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 15, 2024, there were 10 analysts who downgraded Repligen Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Repligen Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Repligen Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Repligen Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Repligen Corp (RGEN) by visiting AAII Stock Evaluator.

Relative Price Strength of Repligen Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 15, 2024, Repligen Corp has a weighted four-quarter relative price strength of -6.01%, which translates to a Momentum Score of 45 and is considered to be Average.

Want to learn more about how Repligen Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Repligen Corp Stock Price: Bottom Line

As of August 16, 2024, Repligen Corp’s stock price is $147.55, which is down 9.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Repligen Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.